Article
RNF43 in cancer: Molecular understanding and clinical significance in immunotherapy.
The journal of gene medicine - 1 Aug 2024
Huo Xingfa, Han Weizhong, Yang Zhen, Lu Yongzhi, Liu Ning, Hou Helei
Abstract excerpt
Identifying biomarkers to predict immune checkpoint inhibitor (ICI) efficacy is warranted. Considering that somatic mutation-derived neoantigens induce strong immune responses, patients with a high tumor mutational burden reportedly tend to respond to ICIs. Therefore, the original function of neoantigenic mutations and their impact on the tumor microenvironment (TME) require attention. RNF43 is a type of RING E3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
